Use of tezepelumab for chronic rhinosinusitis with nasal polyps by eosinophilic endotype: WAYPOINT post-hoc analysis

Study limitation reported by the research below: “This is a post-hoc subgroup analysis; results should be interpreted with caution and are hypothesis-generating rather than confirmatory.”